Levetiracetam

Category: pharmacological

Aliases: Keppra

Pharmacological Mechanism

Pyrrolidone antiseizure — binds synaptic vesicle protein 2A (SV2A) reducing synaptic neurotransmitter release. Broad-spectrum + best-tolerated newer antiseizure agent. Renally cleared, no CYP — DDI-light. Behavioral side effects (irritability, depression) in some patients.

Half-Life (t½)

PO: 7.3h, IV: 7.3h

Dosing Guidelines

Target Organ Systems